| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 742,4 k € | +75.4% | 423,4 k € | +11.0% | 381,3 k € | +55.3% | 245,6 k € | +4.8% | 234,4 k € | -35.4% | 363,0 k € | +15.1% | 315,2 k € | +51.3% | 208,3 k € | -28.0% | 289,2 k € | -10.0% | 321,4 k € | +11.0% | 289,5 k € | |
| EBITDA | 503,1 k € | +105.5% | 244,8 k € | +40.9% | 173,7 k € | +367.5% | 37,2 k € | -0.8% | 37,5 k € | -70.9% | 128,8 k € | +148.1% | 51,9 k € | +168.4% | -75,9 k € | -593.8% | -10,9 k € | -150.6% | 21,6 k € | -68.5% | 68,6 k € | |
| Operating profit | 321,1 k € | +50.2% | 213,8 k € | +63.8% | 130,5 k € | +1495.4% | 8,2 k € | -71.6% | 28,8 k € | -75.9% | 119,4 k € | +246.2% | 34,5 k € | +137.7% | -91,5 k € | -227.6% | -27,9 k € | -702.6% | 4,6 k € | -91.1% | 52,3 k € | |
| Profit/loss | 207,6 k € | +28.8% | 161,1 k € | +61.9% | 99,5 k € | +1814.8% | 5,2 k € | -74.4% | 20,3 k € | -79.8% | 100,5 k € | +192.1% | 34,4 k € | +137.6% | -91,6 k € | -228.4% | -27,9 k € | -2420.7% | -1,1 k € | -103.6% | 30,9 k € | |
| Equity | 1,1 M € | +22.1% | 903,3 k € | +20.8% | 747,8 k € | +15.4% | 648,3 k € | +42.1% | 456,2 k € | +4.7% | 435,9 k € | +30.0% | 335,4 k € | +11.4% | 301,0 k € | -23.3% | 392,5 k € | +711.1% | 48,4 k € | -2.2% | 49,5 k € | |
| Total assets | 1,5 M € | +23.8% | 1,2 M € | +23.6% | 980,7 k € | +9.2% | 898,5 k € | +10.3% | 814,3 k € | +22.8% | 663,0 k € | -0.9% | 669,0 k € | +16.0% | 576,8 k € | -16.7% | 692,5 k € | +12.6% | 615,2 k € | +82.5% | 337,0 k € | |
| Cash | 318,0 k € | -36.8% | 502,7 k € | -8.0% | 546,6 k € | +30.4% | 419,3 k € | -2.1% | 428,3 k € | +119.3% | 195,2 k € | +49.9% | 130,2 k € | +46.8% | 88,7 k € | -45.0% | 161,3 k € | +217.0% | 50,9 k € | +199.2% | 17,0 k € | |
| Debts | 252,8 k € | -17.9% | 308,0 k € | +32.2% | 233,0 k € | -6.9% | 250,3 k € | -30.1% | 358,2 k € | +57.7% | 227,1 k € | -31.9% | 333,7 k € | +21.0% | 275,8 k € | -8.1% | 299,9 k € | -47.1% | 566,8 k € | +97.7% | 286,7 k € | |
| Staff | 2,9 | 2,5 | — | — | 3,7 | 4,5 | 4,8 | 5,5 | 5,5 | 5,8 | 4 | |||||||||||
Private limited company · Namur · incorporated on 13/12/2014 · 2,9 ETP
Private limited company profitable and well capitalised. Cash position declining (-36.8%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
SOCIETE SCIENTIFIQUE DES PHARMACIENS FRANCOPHONES is a Private limited company incorporated in 2014. Its main activity is: Other education n.e.c.. Its registered office is in Namur. It employs on average 2,9 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette